Program
Finasteride
Also written as “Finasteride 5 mg Tablet, single dose”, “minoxidil + finasteride” and “Finasteride 5 mg tablets”.
Its studies are mostly in Alopecia · Prostatic Hyperplasia · Acne Vulgaris, led by 9 companies.
Drug pageFinasteride: every studyMany companies study it; this page follows only the 17 they lead. All 49 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Dr. Reddy's Laboratoriesits history only | 40 open or running | phase 1since May 27, 2010 | May 27, 2010 | none ahead |
| Teva Pharmaceutical Industriesits history only | 40 open or running | phase 1since Feb 3, 2009 | Feb 3, 2009 | none ahead |
| Il-Yang Pharm.its history only | 21 open or running | phase 3since Oct 6, 2026 | Dec 11, 2025 | Aug 31, 2027phase 3 · NCT07870759 |
| Viatrisits history only | 20 open or running | phase 1since Mar 30, 2008 | Mar 30, 2008 | none ahead |
| Almirallits history only | 10 open or running | phase 1since Jun 1, 2016 | Jun 1, 2016 | none ahead |
| Beijing Dayspring Pharmaceutical Technologyits history only | 10 open or running | phase 2since Jul 1, 2025 | Jul 1, 2025 | none ahead |
| Eloracits history only | 10 open or running | phase 2since Jul 10, 2015 | Jul 10, 2015 | none ahead |
| HairDxits history only | 10 open or running | phase 1since Jan 16, 2010 | Jan 16, 2010 | none ahead |
| Merckits history only | 10 open or running | phase 3since Feb 13, 2012 | Feb 13, 2012 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of every company. Pick one to see its own:
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Mar 30, 2008First studies: 2 phase 1 studies in HealthyNew to ViatrisViatris · NCT00650377, NCT00648791
- Feb 3, 2009Teva Pharmaceutical Industries’ first studies: 2 phase 1 studies in HealthyNew to Teva Pharmaceutical IndustriesTeva Pharmaceutical Industries · NCT00835796, NCT00835666
- Mar 26, 20092 phase 1 studies in HealthyTeva Pharmaceutical Industries · NCT00871247, NCT00870480
- Jan 16, 2010HairDx’s first study: phase 1 study in AlopeciaNew to HairDxHairDx · NCT01052870 · 12 enrolled
- May 27, 2010Dr. Reddy's Laboratories’ first studies: 2 phase 1 studies in HealthyNew to Dr. Reddy's LaboratoriesDr. Reddy's Laboratories · NCT01133457, NCT01133444
- Dec 20, 20102 phase 1 studies in HealthyDr. Reddy's Laboratories · NCT01264302, NCT01264289
- Feb 13, 2012Merck’s first study: phase 3 study in Prostatic HyperplasiaNew to MerckMerck · NCT01534351 · 1 enrolled
- Jul 10, 2015Elorac’s first study: phase 2 study in Acne VulgarisNew to EloracElorac · NCT02502669 · 106 enrolled · United States
- Jun 1, 2016Almirall’s first study: phase 1 study in AlopeciaNew to AlmirallAlmirall · NCT02791243 · 58 enrolled · United Kingdom
- Jul 1, 2025Beijing Dayspring Pharmaceutical Technology’s first study: phase 2 study in AlopeciaNew to Beijing Dayspring Pharmaceutical TechnologyBeijing Dayspring Pharmaceutical Technology · NCT07076706 · 110 enrolled · China
- Dec 11, 2025Il-Yang Pharm.’s first study: phase 1 study in Healthy Adult MaleNew to Il-Yang Pharm.Il-Yang Pharm. · NCT07322991 · 43 enrolled · South Korea
- Oct 6, 2026Phase 3 study in Prostatic HyperplasiaPhase 3 reachedIl-Yang Pharm. · NCT07870759 · 660 planned
Ahead
- Aug 31, 2027Primary completion: phase 3 study in Prostatic HyperplasiaIl-Yang Pharm. · NCT07870759
TargetBeta
“Steroid 5-alpha-reductase 2 inhibitor”ChEMBL 37, by rule
Studies
All 17 led by companies developing it, newest first. Each opens its study page.
| Study | Phase | Status | Led by | Primary completion | Size |
|---|---|---|---|---|---|
| NCT07870759Prostatic Hyperplasia | 3 | Not yet recruiting | Il-Yang Pharm. | Aug 31, 2027 | 660 |
| NCT07322991Healthy Adult Male · South Korea | 1 | Completed | Il-Yang Pharm. | Dec 1, 2025 | 43 |
| NCT07076706Alopecia · China | 2 | Completed | Beijing Dayspring Pharmaceutical Technology | Aug 26, 2025 | 110 |
| NCT02791243Alopecia · United Kingdom | 1 | Completed | Almirall | Jun 2016 | 58 |
| NCT02502669Acne Vulgaris · United States | 2 | Completed | Elorac | Jun 6, 2017 | 106 |
| NCT01534351Prostatic Hyperplasia | 3 | Terminated | Merck | Nov 18, 2013 | 1 |
| NCT01264302Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | Nov 2006 | 26 |
| NCT01264289Healthy · United States | 1 | Completed | Dr. Reddy's Laboratories | Nov 2006 | 26 |
| NCT01133457Healthy · Canada | 1 | Completed | Dr. Reddy's Laboratories | May 2002 | 24 |
| NCT01133444Healthy · Canada | 1 | Completed | Dr. Reddy's Laboratories | Apr 2002 | 24 |
| NCT01052870Alopecia | 1 | Completed | HairDx | Dec 2009 | 12 |
| NCT00871247Healthy · Canada | 1 | Completed | Teva Pharmaceutical Industries | Nov 2004 | 26 |
| NCT00870480Healthy · Canada | 1 | Completed | Teva Pharmaceutical Industries | Nov 2004 | 26 |
| NCT00835796Healthy · United States | 1 | Completed | Teva Pharmaceutical Industries | Jul 2002 | 20 |
| NCT00835666Healthy · United States | 1 | Completed | Teva Pharmaceutical Industries | Jun 2002 | 32 |
| NCT00650377Healthy · United States | 1 | Completed | Viatris | Oct 2004 | 30 |
| NCT00648791Healthy · United States | 1 | Completed | Viatris | Oct 2004 | 29 |
How it is read
Names in the registry
- “Finasteride”, 6 entries
- “Finasteride 5 mg Tablet, single dose”, 3 entries
- “minoxidil + finasteride”, 2 entries
- “Finasteride 5 mg tablets”, 2 entries
- “Finasteride Tablets 5 mg”, 2 entries
Conditions, from the studies’ own filings
- Alopecia, 3 studies
- Prostatic Hyperplasia, 2 studies
- Acne Vulgaris, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.